Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

PE firm Uplift adds Arkansas injury practice to law platform

Private equity firm Uplift Investors has expanded its investment strategy in the legal sector through a new management services organisation partnership with Arkansas-based personal injury firm Rainwater, Holt & Sexton.

Private equity firm Uplift Investors has broadened its scope in the legal industry by establishing a management services organization (MSO) partnership with Arkansas-based personal injury law firm Rainwater, Holt & Sexton. The Connecticut-based investor disclosed that this collaboration marks its sixth venture involving external capital and operational assistance to a law firm via an MSO framework.

Under the terms of the agreement, Uplift’s Orion Legal MSO will furnish Rainwater, Holt & Sexton with an array of non-legal services, encompassing administration, finance, marketing, and technology. It is important to note that the law firm will maintain its ownership by its attorneys. This transaction underscores the increasing reliance of private equity investors on MSOs to gain exposure to the legal services industry while adhering to regulations on non-lawyer ownership of US law firms.

As part of the partnership, Rainwater, Holt & Sexton's partners, Mike Rainwater and Bob Sexton, have been appointed to Orion Legal’s national advisory board. Orion Legal was initiated by Uplift in January as part of the firm's strategic expansion into the legal sector. The platform is currently backing personal injury practices in Georgia, Kentucky, Louisiana, Rhode Island, Tennessee, and Texas.

Written by urgent.news from Private Equity Wire's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at privateequitywire.co.uk →

More in Finance & Markets

CVC, NSSK weigh $3.2bn Kobayashi Pharmaceutical take-private

PE firm CVC Capital Partners and Japanese investment firm Nippon Sangyo Suishin Kiko (NSSK) are considering a bid of more than JPY500bn ($3.2bn) to take Japanese healthcare products company Kobayashi…

  • CVC Capital Partners and NSSK consider $3.2bn joint bid for Kobayashi Pharmaceutical.
  • Takeover aims to privatize company amid red yeast supplement controversy.
  • Oasis Management and Kobayashi family hold significant stakes in the firm.

More from Friday 25 September →